During the past decade, Polyclinique de Limoges conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique de Limoges" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique de Limoges" are "Long-term Adverse Effects" (1 trials), "Metastatic Breast Cancer With a Isolated Brain Progression" (1 trials), "Nivolumab" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Polyclinique de Limoges" in a lesser frequency.

Most popular intervention types in "Polyclinique de Limoges" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Androgen deprivation therapy" (1 trials), "Darolutamide 300 mg" (1 trials), "Hormone therapy" (1 trials), "Pertuzumab" (1 trials) and "Pertuzumab/ Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique de Limoges" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique de Limoges". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Polyclinique de Limoges, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique de Limoges, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Polyclinique de Limoges has several departments that took part in Clinical trials: "Clinique Chenieux; Oncology" - 8 trials